267 related articles for article (PubMed ID: 26277277)
1. Immunological evaluation of OMV(PagL)+Bap(1-487aa) and AbOmpA(8-346aa)+Bap(1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection.
Badmasti F; Ajdary S; Bouzari S; Fooladi AA; Shahcheraghi F; Siadat SD
Mol Immunol; 2015 Oct; 67(2 Pt B):552-8. PubMed ID: 26277277
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic reactivity of recombinant PKF and AbOmpA proteins as serum resistance factors against sepsis of Acinetobacter baumannii.
Bolourchi N; Shahcheraghi F; Shirazi AS; Janani A; Bahrami F; Badmasti F
Microb Pathog; 2019 Jun; 131():9-14. PubMed ID: 30930220
[TBL] [Abstract][Full Text] [Related]
3. Immunization with recombinant DcaP-like protein and AbOmpA revealed protections against sepsis infection of multi-drug resistant Acinetobacter baumannii ST2
Fereshteh S; Ajdary S; Sepehr A; Bolourchi N; Barzi SM; Haririzadeh Jouriani F; Riazi-Rad F; Shahcheraghi F; Badmasti F
Microb Pathog; 2023 Jan; 174():105882. PubMed ID: 36403713
[TBL] [Abstract][Full Text] [Related]
4. Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.
McConnell MJ; Rumbo C; Bou G; Pachón J
Vaccine; 2011 Aug; 29(34):5705-10. PubMed ID: 21679737
[TBL] [Abstract][Full Text] [Related]
5. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Ma Y
Vaccine; 2015 Aug; 33(36):4479-85. PubMed ID: 26207591
[TBL] [Abstract][Full Text] [Related]
6. A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection.
Pulido MR; García-Quintanilla M; Pachón J; McConnell MJ
Vaccine; 2020 Jan; 38(4):719-724. PubMed ID: 31843268
[TBL] [Abstract][Full Text] [Related]
7. Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.
García-Quintanilla M; Pulido MR; Pachón J; McConnell MJ
PLoS One; 2014; 9(12):e114410. PubMed ID: 25485716
[TBL] [Abstract][Full Text] [Related]
8. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
[TBL] [Abstract][Full Text] [Related]
9. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection.
Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y
Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050
[TBL] [Abstract][Full Text] [Related]
10. A Multiepitope Peptide, rOmp22, Encapsulated in Chitosan-PLGA Nanoparticles as a Candidate Vaccine Against
Du X; Xue J; Jiang M; Lin S; Huang Y; Deng K; Shu L; Xu H; Li Z; Yao J; Chen S; Shen Z; Feng G
Int J Nanomedicine; 2021; 16():1819-1836. PubMed ID: 33707942
[TBL] [Abstract][Full Text] [Related]
11. Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap).
Fattahian Y; Rasooli I; Mousavi Gargari SL; Rahbar MR; Darvish Alipour Astaneh S; Amani J
Microb Pathog; 2011 Dec; 51(6):402-6. PubMed ID: 21946278
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with a live attenuated Acinetobacter baumannii deficient in thioredoxin provides protection against systemic Acinetobacter infection.
Ainsworth S; Ketter PM; Yu JJ; Grimm RC; May HC; Cap AP; Chambers JP; Guentzel MN; Arulanandam BP
Vaccine; 2017 Jun; 35(26):3387-3394. PubMed ID: 28522011
[TBL] [Abstract][Full Text] [Related]
13. Outer membrane protein A of Acinetobacter baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cells.
Lee JS; Lee JC; Lee CM; Jung ID; Jeong YI; Seong EY; Chung HY; Park YM
Biochem Pharmacol; 2007 Jun; 74(1):86-97. PubMed ID: 17482145
[TBL] [Abstract][Full Text] [Related]
14. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.
KuoLee R; Harris G; Yan H; Xu HH; Conlan WJ; Patel GB; Chen W
Vaccine; 2015 Jan; 33(1):260-7. PubMed ID: 24699469
[TBL] [Abstract][Full Text] [Related]
15. Vesicle-Mediated Dendritic Cell Activation in
Cai W; Kesavan DK; Cheng J; Vasudevan A; Wang H; Wan J; Abdelaziz MH; Su Z; Wang S; Xu H
J Immunol Res; 2019; 2019():2835256. PubMed ID: 32083139
[No Abstract] [Full Text] [Related]
16. Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.
Luo G; Lin L; Ibrahim AS; Baquir B; Pantapalangkoor P; Bonomo RA; Doi Y; Adams MD; Russo TA; Spellberg B
PLoS One; 2012; 7(1):e29446. PubMed ID: 22253723
[TBL] [Abstract][Full Text] [Related]
17. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.
Singh R; Capalash N; Sharma P
Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492
[TBL] [Abstract][Full Text] [Related]
18. Exploitation of two siderophore receptors, BauA and BfnH, for protection against Acinetobacter baumannii infection.
Aghajani Z; Rasooli I; Mousavi Gargari SL
APMIS; 2019 Dec; 127(12):753-763. PubMed ID: 31512768
[TBL] [Abstract][Full Text] [Related]
19. Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models.
Huang W; Yao Y; Long Q; Yang X; Sun W; Liu C; Jin X; Li Y; Chu X; Chen B; Ma Y
PLoS One; 2014; 9(6):e100727. PubMed ID: 24956279
[TBL] [Abstract][Full Text] [Related]
20. Protective response against
Ramezanalizadeh F; Rasooli I; Owlia P
Future Microbiol; 2021 Feb; 16(3):143-157. PubMed ID: 33528272
[No Abstract] [Full Text] [Related]
[Next] [New Search]